Abcellera Biologics Stock Forecast

Sell candidate since Jul 20, 2026 Loss -1.55%

The AbCellera Biologics Inc. stock price gained 0.351% on the last trading day (Friday, 31st Jul 2026), rising from $5.69 to $5.71. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 6.53% from a day low at $5.51 to a day high of $5.87. The price has been going up and down for this period, and there has been a -11.68% loss for the last 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 672 thousand more shares were traded than the day before. In total, 5 million shares were bought and sold for approximately $28.48 million.

The stock lies in the lower part of a very wide and strong rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $5.37 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 25.49% during the next 3 months and, with a 90% probability hold a price between $6.73 and $11.03 at the end of this 3-month period.

ABCL Signals & Forecast

There are mixed signals in the stock today. The AbCellera Biologics Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $6.29. On a fall, the stock will find some support from the short-term average at $5.47. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. A sell signal was issued from a pivot top point on Monday, June 29, 2026, and so far it has fallen -29.68%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Support, Risk & Stop-loss for AbCellera Biologics Inc. stock

On the downside, the stock finds support just below today's level from accumulated volume at $5.29 and $5.25. There is a natural risk involved when a stock is testing a support level, since if this is broken, the stock then may fall to the next support level. In this case, AbCellera Biologics Inc. finds support just below today's level at $5.29. If this is broken, then the next support from accumulated volume will be at $5.25 and $4.95.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.360 between high and low, or 6.53%. For the last week, the stock has had daily average volatility of 6.65%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (ABCL) For The Upcoming Trading Day Of Monday 3rd

For the upcoming trading day on Monday, 3rd we expect AbCellera Biologics Inc. to open at $5.70, and during the day (based on 14 day Average True Range), to move between $5.47 and $5.95, which gives a possible trading interval of +/-$0.486 (+/-8.89%) up or down from last closing price. If AbCellera Biologics Inc. takes out the full calculated possible swing range there will be an estimated 8.89% move between the lowest and the highest trading price during the day.

Since the stock is closer to the resistance from accumulated volume at $6.03 (5.60%) than the support at $5.29 (7.36%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.

Is AbCellera Biologics Inc. stock A Buy?

AbCellera Biologics Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock.

Current score: -3.538 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on August 3, 2026 - $5.70 ( 0.234%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk